PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Tuberculosis and Respiratory Diseases10.4046/trd.2013.75.5.1812013755181Biopsy and Mutation Detection Strategies in Non-Small Cell Lung CancerChi Young Junghttps://synapse.koreamed.org/DOIx.php?id=10.4046/trd.2013.75.5.181, https://synapse.koreamed.org/pdf/10.4046/trd.2013.75.5.181, http://synapse.koreamed.org/DOIx.php?id=10.4046/trd.2013.75.5.181
Lung Cancer10.1016/s0169-5002(14)70023-6201483S922 Mutation profiling of non-small cell lung cancer small biopsy samples using mass spectrometry and the SequenomLungCarta PanelA.M. Quinn, N. Hickson, M. Adaway, L. Priest, C. Keeling, A. Wallace, D. Nonaka, R. Byers, W. Newman, F.H. Blackhallhttps://api.elsevier.com/content/article/PII:S0169500214700236?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500214700236?httpAccept=text/plain
Respirology10.1111/resp.13419_17620182372-72PROGRESSION-FREE SURVIVAL AMONG PROGRESSED NON-SMALL CELL LUNG CANCER (NSCLC) WITH T790M MUTATION AS GUIDED BY LIQUID BIOPSY IS SHORTER THAN THOSE BASED ON TISSUE RE-BIOPSYhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fresp.13419_176, http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.13419_176/fullpdf
Pathology10.1097/01.pat.0000443727.16500.9c201446S11837. Mutation testing in non-small cell lung cancer - suitability of small biopsy and cytology specimensS. Wang, B. Yu, C.C. Ng, B. Mercorella, S. O’Toole, W.A. Cooperhttps://api.elsevier.com/content/article/PII:S0031302516309795?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0031302516309795?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(01)00359-2200134S145-S150Neoadjuvant strategies for non-small cell lung cancerNico van Zandwijkhttps://api.elsevier.com/content/article/PII:S0169500201003592?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500201003592?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(96)80022-51996153386Observer variability in histopathological reporting of non-small cell lung carcinoma on bronchial biopsy specimenshttps://api.elsevier.com/content/article/PII:S0169500296800225?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500296800225?httpAccept=text/plain
Clinical Lung Cancer10.1016/j.cllc.2016.11.0212017183e187-e196Immunohistochemistry for EGFR Mutation Detection in Non–Small-Cell Lung CancerNina Turnšek Hitij, Izidor Kern, Aleksander Sadikov, Lea Knez, Karmen Stanič, Matjaž Zwitter, Tanja Cuferhttps://api.elsevier.com/content/article/PII:S1525730416303758?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1525730416303758?httpAccept=text/plain
Lung Cancer10.1016/0169-5002(96)84334-01995133348Integration of vinorelbine into chemotherapy strategies for non-small-cell lung cancerhttps://api.elsevier.com/content/article/PII:0169500296843340?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0169500296843340?httpAccept=text/plain
Lung Cancer10.1016/0169-5002(94)93796-61994117A tentative K-ras gene mutation-based genotypic classification of non-small cell lung cancer (NSCLC)https://api.elsevier.com/content/article/PII:0169500294937966?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0169500294937966?httpAccept=text/plain
Chest10.1016/j.chest.2019.02.15520191554161APROPORTION OF EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION FROM LIQUID BIOPSY CT-DNA PLASMA IN NON-SMALL CELL LUNG CANCER TYPES OF ADENOCARSINOMAH. Taufikhttps://api.elsevier.com/content/article/PII:S0012369219303435?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0012369219303435?httpAccept=text/plain